Lung cancer proved the second-most discussed cancer type during ASCO 2025, totalling 2,995 mentions by more than 530 HCPs. As ...

Antibody-drug conjugates (ADCs) hit the scene in oncology many moons ago – in fact, this year marks 25 years since the first ...

The JCA process was passed into law by the European Union in 2022. The Joint Clinical Assessment is a process that will ...

AstraZeneca and Daiichi Sankyo's TROP2-directed antibody-drug conjugate (ADC) Datroway has been granted accelerated approval ...

Cambridge, Massachusetts-based Nuvalent has reported the results of its phase 1/2 ARROS-1 trial of zidesamtinib in previously ...

In a statement, Novo Nordisk said that it was terminating the collaboration "due to concerns about their illegal mass ...

One-year results from the company's FORWARD-101 trial of islet cell therapy zimislecel (also known as VX-880) showed that all ...

Medistry’s role is that of the registry operator of the .med zone on the World Wide Web. Medistry permits authorised domain ...

Louisiana Senator Bill Cassidy, who chairs the Senate Health, Education, Labor, & Pensions (HELP) Committee, has called for ...

Returning to Boston for its 13 th edition, the IMPACCT Real-World Evidence Summit remains the go-to meeting for RWE experts ...

The pharma group has presented phase 1/2 results with new candidate NXT007 at the International Society on Thrombosis and ...

Around half of people diagnosed with pancreatic cancer will have been diagnosed with diabetes recently, according to NHS ...